Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients

BACKGROUNDS AND PURPOSE: Concurrent non-alcoholic fatty liver disease (NAFLD) in chronic hepatitis B (CHB) patients is a frequent and increasingly concerning problem because of the NAFLD pandemic. Admittedly, NAFLD can progress to non-alcoholic steatohepatitis (NASH) and severe fibrosis. Direct evid...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yan, Gan, Qinyi, Lai, Rongtao, Wang, Weijing, Guo, Simin, Sheng, Zike, Chen, Lu, Guo, Qing, Cai, Wei, Wang, Hui, Zhao, Gangde, Cao, Zhujun, Xie, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801606/
https://www.ncbi.nlm.nih.gov/pubmed/35111690
http://dx.doi.org/10.3389/fcimb.2021.733348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801606/
https://www.ncbi.nlm.nih.gov/pubmed/35111690
http://dx.doi.org/10.3389/fcimb.2021.733348

Ejemplares similares